GC Wealth Management RIA, LLC

Position in AMGN — Amgen Inc

CIK 2011169 Cambridge, MA

Position in AMGN

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$2,199,154

-$30,167 QoQ

Shares Held

6,073

-4.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#1,232

of 3,140 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GC Wealth Management RIA, LLC holds $51,496,913 across 12 Drug Manufacturers - General names. AMGN ranks #6 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	18,328	$21,983,154
2	ABBV	AbbVie Inc.	37,102	$9,336,347
3	MRK	Merck & Co., Inc.	39,089	$5,022,936
4	JNJ	Johnson & Johnson	18,773	$4,767,778
5	AZN	Astrazeneca PLC	18,143	$3,440,275
6	AMGN	Amgen Inc This page	6,073	$2,199,154
7	NVO	Novo Nordisk A S	39,641	$1,900,389
8	NVS	Novartis AG	6,349	$995,015

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,199,154	6,073	-4.2%	Shares	Sole	2026-07-16
2026-03-31	$2,229,321	6,336	-6.1%	Shares	Sole	2026-05-14
2025-12-31	$2,209,669	6,751	-46.5%	Shares	Sole	2026-01-30
2025-09-30	$3,563,339	12,627	+52.4%	Shares	Sole	2025-11-13
2025-06-30	$2,313,813	8,287	+77.3%	Shares	Sole	2025-07-17
2025-03-31	$1,455,873	4,673	+4.7%	Shares	Sole	2025-05-12
2024-12-31	$1,163,496	4,464	+5.2%	Shares	Sole	2025-02-07
2024-09-30	$1,367,459	4,244	-3.9%	Shares	Sole	2024-11-04
2024-06-30	$1,379,779	4,416	+0.2%	Shares	Sole	2024-07-31
2024-03-31	$1,253,282	4,408	+366.5%	Shares	Sole	2024-05-10
2023-12-31	$272,178	945	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.